tris(4-hydroxypent-3-en-2-one);tetrakis(iridium);bis(methyl(diphenyl)phosphanium);4-methyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;osmium(1+);2-phenyl-3-phenylpyrazine;2-phenyl-3-phenylquinoxaline;2-phenyl-3-phenyl-5,6,7,8-tetrahydroquinoxaline;2-phenylpyridine;platinum;2-pyridin-2-ylpyridine;2-(3H-thiophen-3-id-2-yl)pyridine

C136H121F3Ir4N14O6OsP2PtS-3 — CID 159729407

IUPACtris(4-hydroxypent-3-en-2-one);tetrakis(iridium);bis(methyl(diphenyl)phosphanium);4-methyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;osmium(1+);2-phenyl-3-phenylpyrazine;2-phenyl-3-phenylquinoxaline;2-phenyl-3-phenyl-5,6,7,8-tetrahydroquinoxaline;2-phenylpyridine;platinum;2-pyridin-2-ylpyridine;2-(3H-thiophen-3-id-2-yl)pyridine
SMILESCC(=O)C=C(C)O.CC(=O)C=C(C)O.CC(=O)C=C(C)O.C[PH+](c1ccccc1)c1ccccc1.C[PH+](c1ccccc1)c1ccccc1.Cc1ccnc(-c2nc(C(F)(F)F)n[n-]2)c1.[Ir].[Ir].[Ir].[Ir].[Os+].[Pt].[c-]1ccccc1-c1ccccn1.[c-]1ccccc1-c1nc2c(nc1-c1ccccc1)CCCC2.[c-]1ccccc1-c1nc2ccccc2nc1-c1ccccc1.[c-]1ccccc1-c1nccnc1-c1ccccc1.[c-]1ccsc1-c1ccccn1.c1ccc(-c2ccccn2)nc1
InChIInChI=1S/C20H17N2.C20H13N2.C16H11N2.2C13H13P.C11H8N.C10H8N2.C9H6F3N4.C9H6NS.3C5H8O2.4Ir.Os.Pt/c2*1-3-9-15(10-4-1)19-20(16-11-5-2-6-12-16)22-18-14-8-7-13-17(18)21-19;1-3-7-13(8-4-1)15-16(18-12-11-17-15)14-9-5-2-6-10-14;2*1-14(12-8-4-2-5-9-12)13-10-6-3-7-11-13;1-2-6-10(7-3-1)11-8-4-5-9-12-11;1-3-7-11-9(5-1)10-6-2-4-8-12-10;1-5-2-3-13-6(4-5)7-14-8(16-15-7)9(10,11)12;1-2-6-10-8(4-1)9-5-3-7-11-9;3*1-4(6)3-5(2)7;;;;;;/h1-6,9-11H,7-8,13-14H2;1-11,13-14H;1-9,11-12H;2*2-11H,1H3;1-6,8-9H;1-8H;2-4H,1H3;1-4,6-7H;3*3,6H,1-2H3;;;;;;/q3*-1;;;-1;;2*-1;;;;;;;;+1;/p+2
InChIKeyXXQPETRZZFKMFM-UHFFFAOYSA-P
MW3352.74 g/mol
LogP30.05
Rot. Bonds17

About tris(4-hydroxypent-3-en-2-one);tetrakis(iridium);bis(methyl(diphenyl)phosphanium);4-methyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;osmium(1+);2-phenyl-3-phenylpyrazine;2-phenyl-3-phenylquinoxaline;2-phenyl-3-phenyl-5,6,7,8-tetrahydroquinoxaline;2-phenylpyridine;platinum;2-pyridin-2-ylpyridine;2-(3H-thiophen-3-id-2-yl)pyridine

tris(4-hydroxypent-3-en-2-one);tetrakis(iridium);bis(methyl(diphenyl)phosphanium);4-methyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;osmium(1+);2-phenyl-3-phenylpyrazine;2-phenyl-3-phenylquinoxaline;2-phenyl-3-phenyl-5,6,7,8-tetrahydroquinoxaline;2-phenylpyridine;platinum;2-pyridin-2-ylpyridine;2-(3H-thiophen-3-id-2-yl)pyridine (PubChem CID 159729407) has the molecular formula C136H121F3Ir4N14O6OsP2PtS-3 and a molecular weight of 3352.74 g/mol. Its IUPAC name is tris(4-hydroxypent-3-en-2-one);tetrakis(iridium);bis(methyl(diphenyl)phosphanium);4-methyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;osmium(1+);2-phenyl-3-phenylpyrazine;2-phenyl-3-phenylquinoxaline;2-phenyl-3-phenyl-5,6,7,8-tetrahydroquinoxaline;2-phenylpyridine;platinum;2-pyridin-2-ylpyridine;2-(3H-thiophen-3-id-2-yl)pyridine.

Molecular Properties

Compound Nametris(4-hydroxypent-3-en-2-one);tetrakis(iridium);bis(methyl(diphenyl)phosphanium);4-methyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;osmium(1+);2-phenyl-3-phenylpyrazine;2-phenyl-3-phenylquinoxaline;2-phenyl-3-phenyl-5,6,7,8-tetrahydroquinoxaline;2-phenylpyridine;platinum;2-pyridin-2-ylpyridine;2-(3H-thiophen-3-id-2-yl)pyridine
PubChem CID159729407
Molecular FormulaC136H121F3Ir4N14O6OsP2PtS-3
Molecular Weight3352.74 g/mol
Exact Mass3355.65
IUPAC Nametris(4-hydroxypent-3-en-2-one);tetrakis(iridium);bis(methyl(diphenyl)phosphanium);4-methyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;osmium(1+);2-phenyl-3-phenylpyrazine;2-phenyl-3-phenylquinoxaline;2-phenyl-3-phenyl-5,6,7,8-tetrahydroquinoxaline;2-phenylpyridine;platinum;2-pyridin-2-ylpyridine;2-(3H-thiophen-3-id-2-yl)pyridine
SMILESCC(=O)C=C(C)O.CC(=O)C=C(C)O.CC(=O)C=C(C)O.C[PH+](c1ccccc1)c1ccccc1.C[PH+](c1ccccc1)c1ccccc1.Cc1ccnc(-c2nc(C(F)(F)F)n[n-]2)c1.[Ir].[Ir].[Ir].[Ir].[Os+].[Pt].[c-]1ccccc1-c1ccccn1.[c-]1ccccc1-c1nc2c(nc1-c1ccccc1)CCCC2.[c-]1ccccc1-c1nc2ccccc2nc1-c1ccccc1.[c-]1ccccc1-c1nccnc1-c1ccccc1.[c-]1ccsc1-c1ccccn1.c1ccc(-c2ccccn2)nc1
InChIInChI=1S/C20H17N2.C20H13N2.C16H11N2.2C13H13P.C11H8N.C10H8N2.C9H6F3N4.C9H6NS.3C5H8O2.4Ir.Os.Pt/c2*1-3-9-15(10-4-1)19-20(16-11-5-2-6-12-16)22-18-14-8-7-13-17(18)21-19;1-3-7-13(8-4-1)15-16(18-12-11-17-15)14-9-5-2-6-10-14;2*1-14(12-8-4-2-5-9-12)13-10-6-3-7-11-13;1-2-6-10(7-3-1)11-8-4-5-9-12-11;1-3-7-11-9(5-1)10-6-2-4-8-12-10;1-5-2-3-13-6(4-5)7-14-8(16-15-7)9(10,11)12;1-2-6-10-8(4-1)9-5-3-7-11-9;3*1-4(6)3-5(2)7;;;;;;/h1-6,9-11H,7-8,13-14H2;1-11,13-14H;1-9,11-12H;2*2-11H,1H3;1-6,8-9H;1-8H;2-4H,1H3;1-4,6-7H;3*3,6H,1-2H3;;;;;;/q3*-1;;;-1;;2*-1;;;;;;;;+1;/p+2
InChIKeyXXQPETRZZFKMFM-UHFFFAOYSA-P
XLogP30.05
TPSA293.57 Ų
H-Bond Donors3
H-Bond Acceptors20
Rotatable Bonds17
Heavy Atoms168
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003352.74
LogP ≤ 530.05
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze tris(4-hydroxypent-3-en-2-one);tetrakis(iridium);bis(methyl(diphenyl)phosphanium);4-methyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;osmium(1+);2-phenyl-3-phenylpyrazine;2-phenyl-3-phenylquinoxaline;2-phenyl-3-phenyl-5,6,7,8-tetrahydroquinoxaline;2-phenylpyridine;platinum;2-pyridin-2-ylpyridine;2-(3H-thiophen-3-id-2-yl)pyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of tris(4-hydroxypent-3-en-2-one);tetrakis(iridium);bis(methyl(diphenyl)phosphanium);4-methyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;osmium(1+);2-phenyl-3-phenylpyrazine;2-phenyl-3-phenylquinoxaline;2-phenyl-3-phenyl-5,6,7,8-tetrahydroquinoxaline;2-phenylpyridine;platinum;2-pyridin-2-ylpyridine;2-(3H-thiophen-3-id-2-yl)pyridine?
The IUPAC name of tris(4-hydroxypent-3-en-2-one);tetrakis(iridium);bis(methyl(diphenyl)phosphanium);4-methyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;osmium(1+);2-phenyl-3-phenylpyrazine;2-phenyl-3-phenylquinoxaline;2-phenyl-3-phenyl-5,6,7,8-tetrahydroquinoxaline;2-phenylpyridine;platinum;2-pyridin-2-ylpyridine;2-(3H-thiophen-3-id-2-yl)pyridine (CID 159729407) is tris(4-hydroxypent-3-en-2-one);tetrakis(iridium);bis(methyl(diphenyl)phosphanium);4-methyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;osmium(1+);2-phenyl-3-phenylpyrazine;2-phenyl-3-phenylquinoxaline;2-phenyl-3-phenyl-5,6,7,8-tetrahydroquinoxaline;2-phenylpyridine;platinum;2-pyridin-2-ylpyridine;2-(3H-thiophen-3-id-2-yl)pyridine.
What is the SMILES notation for tris(4-hydroxypent-3-en-2-one);tetrakis(iridium);bis(methyl(diphenyl)phosphanium);4-methyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;osmium(1+);2-phenyl-3-phenylpyrazine;2-phenyl-3-phenylquinoxaline;2-phenyl-3-phenyl-5,6,7,8-tetrahydroquinoxaline;2-phenylpyridine;platinum;2-pyridin-2-ylpyridine;2-(3H-thiophen-3-id-2-yl)pyridine?
The canonical SMILES for tris(4-hydroxypent-3-en-2-one);tetrakis(iridium);bis(methyl(diphenyl)phosphanium);4-methyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;osmium(1+);2-phenyl-3-phenylpyrazine;2-phenyl-3-phenylquinoxaline;2-phenyl-3-phenyl-5,6,7,8-tetrahydroquinoxaline;2-phenylpyridine;platinum;2-pyridin-2-ylpyridine;2-(3H-thiophen-3-id-2-yl)pyridine is CC(=O)C=C(C)O.CC(=O)C=C(C)O.CC(=O)C=C(C)O.C[PH+](c1ccccc1)c1ccccc1.C[PH+](c1ccccc1)c1ccccc1.Cc1ccnc(-c2nc(C(F)(F)F)n[n-]2)c1.[Ir].[Ir].[Ir].[Ir].[Os+].[Pt].[c-]1ccccc1-c1ccccn1.[c-]1ccccc1-c1nc2c(nc1-c1ccccc1)CCCC2.[c-]1ccccc1-c1nc2ccccc2nc1-c1ccccc1.[c-]1ccccc1-c1nccnc1-c1ccccc1.[c-]1ccsc1-c1ccccn1.c1ccc(-c2ccccn2)nc1.
What is the InChIKey of tris(4-hydroxypent-3-en-2-one);tetrakis(iridium);bis(methyl(diphenyl)phosphanium);4-methyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;osmium(1+);2-phenyl-3-phenylpyrazine;2-phenyl-3-phenylquinoxaline;2-phenyl-3-phenyl-5,6,7,8-tetrahydroquinoxaline;2-phenylpyridine;platinum;2-pyridin-2-ylpyridine;2-(3H-thiophen-3-id-2-yl)pyridine?
The InChIKey is XXQPETRZZFKMFM-UHFFFAOYSA-P. The full InChI is InChI=1S/C20H17N2.C20H13N2.C16H11N2.2C13H13P.C11H8N.C10H8N2.C9H6F3N4.C9H6NS.3C5H8O2.4Ir.Os.Pt/c2*1-3-9-15(10-4-1)19-20(16-11-5-2-6-12-16)22-18-14-8-7-13-17(18)21-19;1-3-7-13(8-4-1)15-16(18-12-11-17-15)14-9-5-2-6-10-14;2*1-14(12-8-4-2-5-9-12)13-10-6-3-7-11-13;1-2-6-10(7-3-1)11-8-4-5-9-12-11;1-3-7-11-9(5-1)10-6-2-4-8-12-10;1-5-2-3-13-6(4-5)7-14-8(16-15-7)9(10,11)12;1-2-6-10-8(4-1)9-5-3-7-11-9;3*1-4(6)3-5(2)7;;;;;;/h1-6,9-11H,7-8,13-14H2;1-11,13-14H;1-9,11-12H;2*2-11H,1H3;1-6,8-9H;1-8H;2-4H,1H3;1-4,6-7H;3*3,6H,1-2H3;;;;;;/q3*-1;;;-1;;2*-1;;;;;;;;+1;/p+2.
What are the key properties of tris(4-hydroxypent-3-en-2-one);tetrakis(iridium);bis(methyl(diphenyl)phosphanium);4-methyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;osmium(1+);2-phenyl-3-phenylpyrazine;2-phenyl-3-phenylquinoxaline;2-phenyl-3-phenyl-5,6,7,8-tetrahydroquinoxaline;2-phenylpyridine;platinum;2-pyridin-2-ylpyridine;2-(3H-thiophen-3-id-2-yl)pyridine?
tris(4-hydroxypent-3-en-2-one);tetrakis(iridium);bis(methyl(diphenyl)phosphanium);4-methyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;osmium(1+);2-phenyl-3-phenylpyrazine;2-phenyl-3-phenylquinoxaline;2-phenyl-3-phenyl-5,6,7,8-tetrahydroquinoxaline;2-phenylpyridine;platinum;2-pyridin-2-ylpyridine;2-(3H-thiophen-3-id-2-yl)pyridine has a molecular weight of 3352.74 g/mol, XLogP of 30.05, 17 rotatable bonds, 3 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for tris(4-hydroxypent-3-en-2-one);tetrakis(iridium);bis(methyl(diphenyl)phosphanium);4-methyl-2-[5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-dien-3-yl]pyridine;osmium(1+);2-phenyl-3-phenylpyrazine;2-phenyl-3-phenylquinoxaline;2-phenyl-3-phenyl-5,6,7,8-tetrahydroquinoxaline;2-phenylpyridine;platinum;2-pyridin-2-ylpyridine;2-(3H-thiophen-3-id-2-yl)pyridine is sourced from PubChem (CID 159729407), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).